Vimarsana
Biggest News Aggregation in the World

Tissuecypher Barrett News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tissuecypher Barrett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tissuecypher Barrett Today - Breaking & Trending Today

Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2023 Earnings Call Transcript - Vimarsana News

Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2023 Conference Call. As a reminder, today's call is being recorded.

Castle Biosciences Reports Third Quarter 2023 Results - Vimarsana News

Castle Biosciences Reports Third Quarter 2023 Results

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Nov 2, 2023--

Castle Biosciences Reports Third Quarter 2023 Results - Vimarsana News

Castle Biosciences Reports Third Quarter 2023 Results

Q3 2023 revenue increased 66% over Q3 2022 to $61 million Q3 2023 total test reports increased 52% over Q3 2022 Raising full year 2023 revenue guidance to at least $200 million from at least $180...

TissueCypher® Barrett's Esophagus Test Outperformed Standard of Care in Risk-Stratifying Patients with Barrett's Esophagus - Vimarsana News

TissueCypher® Barrett's Esophagus Test Outperformed Standard of Care in Risk-Stratifying Patients with Barrett's Esophagus

The study, published in Gastroenterology, shows TissueCypher can increase the detection of Barrett’s esophagus patients with an initial diagnosis of low-grade dysplasia who will progress to...

New Publication Highlights the Ability of the TissueCypher® Barrett's Esophagus Test to Improve and Standardize the Clinical Management of Low-Grade Dysplasia in Patients with Barrett's Esophagus - Vimarsana News

New Publication Highlights the Ability of the TissueCypher® Barrett's Esophagus Test to Improve and Standardize the Clinical Management of Low-Grade Dysplasia in Patients with Barrett's Esophagus

In the study, management decisions were simulated to determine the most likely care plan with or without use of the TissueCypher test for guidance Study data shows TissueCypher test results...